Group Chief Operating Officer
Prof Vinodh Edward
Prof Vinodh Edward has been a basic sciences researcher since 2000 and has been involved in clinical research management since 2005. He is a registered professional natural scientist, which allows him to have a broad focus in the biological sciences. He is highly experienced in working with various international donors and delivering various projects simultaneously.
Prof. Edward is the Group Chief Operating Officer at The Aurum Institute. He is also the founder and CEO of Global Health Innovations (an Aurum Group company). Prof. Edward has been a basic sciences researcher since 2000. He has been involved in clinical research management since 2005. His registration as a professional natural scientist, allows him to have a broad focus in the biological sciences. He is highly experienced in working with various international donors and delivering various projects simultaneously. Prof. Edward is passionate about building clinical research capacity throughout Africa and strives to achieve efficiencies in all facets of research.
As Prof. Edward oversees the South African arm of Aurum which has more than 2000 employees, more than 70 active grants and an annual operating budget exceeding R1.25 billion. He is currently the Aurum Principal Investigator for the USAID funded IAVI ADVANCE Program. Prof. Edward is also a co-investigator on a number of clinical trials at Aurum.
Prof. Edward holds a Bachelor of Science degree with majors in Microbiology and Physiology as well as a Doctor of Technology Degree in Biotechnology. He has published in the areas of basic sciences and clinical research. He currently holds an adjunct position at Vanderbilt University and an honorary position at the University of KwaZulu-Natal. He is the co-chair of the Wits Institutional Biosafety Committee. Prof. Edward is also a member of the board of trustees at the Madibeng Centre for Research.
Journal Articles
-
Price, M.A., Kuteesa, M., Oladimeji, M., Brumskine, W., Edward, V., Makkan, H., Mthembu, F., Muturi-Kioi, V., Chetty-Makkan, C. and Maenetje, P., 2024. High STI burden among a cohort of adolescents aged 12–19 years in a youth-friendly clinic in South Africa. Plos one, 19(7), p.e0306771.
-
Makkan, H., Wangui Machira, Y., Mthembu, F., Masibi, O., Molefe, T., Maenetje, P., Muturi-Kioi, V., Price, M.A., Edward, V.A. and Chetty-Makkan, C., 2024. Adolescent choices and caregiver roles: Understanding individual and interpersonal influences on sexual decision-making in South Africa. PLOS Global Public Health, 4(12), p.e0003569.
-
Edward, V.A., Chuturgoon, A.A. and Lalla-Edward, S.T., 2023. Contemporary strategies: advancing healthcare for HIV, STIs, and beyond. Frontiers in Reproductive Health, 5, p.1259732.
-
Makkan, H., Maenetje, P., Chetty-Makkan, C.M., Muchiri, E., Latka, M.H., Edward, V.A., Price, M.A., Omosa-Manyonyi, G. and Lindan, C., 2022. Attitudes Toward Gender-Based Violence Among Sexually Active Adult Men at High Risk for HIV in Rustenburg, South Africa. American journal of men's health, 16(3), p.15579883221106331.
-
Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Likoti, M., Sebe, M., Edward, V.A., Rassool, M., Ahmed, K., Fielding, K. and Ahidjo, B.A., 2022. Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial. Plos one, 17(2), p.e0252097.
-
Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Likoti, M., Sebe, M., Edward, V.A., Rassool, M., Ahmed, K., Fielding, K. and Ahidjo, B.A., 2022. Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial. Plos one, 17(2), p.e0252097.
-
Duma, Z., Chuturgoon, A.A., Ramsuran, V., Edward, V., Naidoo, P., Mpaka-Mbatha, M.N., Bhengu, K.N., Nembe, N., Pillay, R., Singh, R. and Mkhize-Kwitshana, Z.L., 2022. The challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings. Globalization and Health, 18(1), pp.1-10.
-
Wallis, R.S., Ginindza, S., Beattie, T., Arjun, N., Sebe, M., Likoti, M., Edward, V.A., Rassool, M., Ahmed, K., Fielding, K. and Ahidjo, B.A., 2021. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. The Lancet Respiratory Medicine.
-
Dees, J., Philip, N., Lind, M., Ahmed, K., Batting, J., Beksinska, M., Edward, V.A., Louw, C.E., Onono, M., Palanee-Phillips, T. and Smit, J.A., 2020. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant. Sexually Transmitted Infections.
-
Price, M.A., Kilembe, W., Ruzagira, E., Karita, E., Inambao, M., Sanders, E.J., Anzala, O., Allen, S., Edward, V.A., Kaleebu, P. and Fast, P.E., 2021. Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery. International Journal of Epidemiology, 50(1), pp.29-30.
-
Price, M. A., Rida, W., Kilembe, W., Karita, E., Inambao, M., Ruzagira, E., Kamali, A., Sanders, E. J., Anzala, O., Hunter, E., Allen, S., Edward, V. A., Wall, K. M., Tang, J., Fast, P. E., Kaleebu, P., Lakhi, S., Mutua, G., Bekker, L. G., Abu-Baker, G., … Gilmour, J. (2019). Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection. The Journal of infectious diseases, 220(3), 432–441.
-
Maenetje, P., Lindan, C., Makkan, H., Chetty-Makkan, C.M., Latka, M.H., Charalambous, S., Mlotshwa, M., Malefo, M., Brumskine, W., Hills, N.K., Price, M.A., and Edward, V., 2019. HIV incidence and predictors of inconsistent condom use among adult men enrolled into an HIV vaccine preparedness study, Rustenburg, South Africa. PloS one, 14(4), p.e0214786.
